Zynex logo

ZynexNASDAQ: ZYXI

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 February 2004

Next earnings report:

26 July 2024

Last dividends:

05 January 2022

Next dividends:

N/A
$283.12 M
-54%vs. 3y high
59%vs. sector
-67%vs. 3y high
68%vs. sector
-30%vs. 3y high
93%vs. sector
-74%vs. 3y high
32%vs. sector

Price

after hours | Wed, 03 Jul 2024 20:33:19 GMT
$8.91-$0.18(-1.98%)
$46.53 M$52.09 M
$46.53 M$10.00 K

Analysts recommendations

Institutional Ownership

ZYXI Latest News

All You Need to Know About Zynex (ZYXI) Rating Upgrade to Buy
zacks.com26 June 2024 Sentiment: -

Zynex (ZYXI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024
prnewswire.com10 June 2024 Sentiment: -

ENGLEWOOD, Colo. , June 10, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it will participate in an analyst-led fireside chat on an RBC Capital Markets 2024 Medical Device Strategy & Innovation Call at 11:00 AM ET on Thursday, June 13, 2024.

Zynex (ZYXI) is an Incredible Growth Stock: 3 Reasons Why
zacks.com23 May 2024 Sentiment: POSITIVE

Zynex (ZYXI) possesses solid growth attributes, which could help it handily outperform the market.

Zynex (ZYXI) CEO on the Medical Device Industry
Schwab Network01 March 2024 Sentiment: POSITIVE

Zynex (ZYXI) is a medical device manufacturer with products for pain management, injury rehab, and medical monitoring. CEO Thomas Sandgaard joins Oliver Renick to discuss the company's earnings.

Zynex, Inc. (ZYXI) Q4 2023 Earnings Call Transcript
Seeking Alpha29 February 2024 Sentiment: POSITIVE

Zynex, Inc. (ZYXI) Q4 2023 Earnings Call Transcript

Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates
Zacks Investment Research29 February 2024 Sentiment: NEGATIVE

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.20 per share a year ago.

Zynex Inc. (ZYXI) Q3 Earnings Match Estimates
Zacks Investment Research26 October 2023 Sentiment: POSITIVE

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.13 per share a year ago.

Zynex: A Reassessment
Seeking Alpha03 October 2023 Sentiment: POSITIVE

Zynex, Inc. is a pain management company that manufactures and markets medical devices for chronic and acute pain treatment. The stock has fallen by half since we took a first look at it in April despite being profitable and having better than 20% revenue growth. Is Zynex now in the 'buy zone?" An updated analysis follows in the paragraphs below.

Zynex to Present at the Cantor Global Healthcare Conference
PRNewsWire19 September 2023 Sentiment: POSITIVE

ENGLEWOOD, Colo. , Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming Cantor Global Healthcare Conference, which is being held September 26 th-28th, 2023.

Zynex, Inc. (ZYXI) Q2 2023 Earnings Call Transcript
Seeking Alpha27 July 2023 Sentiment: POSITIVE

Zynex, Inc. (NASDAQ:ZYXI ) Q2 2023 Earnings Conference Call July 27, 2023 4:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive Officer Anna Lucsok - Chief Operating Officer Donald Gregg - Vice President, Zynex Monitoring Solutions Daniel Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen, and welcome to the Zynex Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

What type of business is Zynex?

Zynex, Inc. is a manufacturer of medical equipment specializing in electrotherapeutic devices used in pain management, physical rehabilitation, neurological diagnostics, and cardiac monitoring. The company was founded in 1996 and is headquartered in Englewood, Colorado. The company designs, manufactures, and sells its own medical devices through three subsidiaries: Zynex Medical provides products for home use electrotherapy. Zynex Monitoring Solutions develops heart monitoring products for hospital use. Zynex NeuroDiagnostics develops EMG and EEG diagnostic devices for neurological clinics.

What sector is Zynex in?

Zynex is in the Healthcare sector

What industry is Zynex in?

Zynex is in the Medical Distribution industry

What country is Zynex from?

Zynex is headquartered in United States

When did Zynex go public?

Zynex initial public offering (IPO) was on 25 February 2004

What is Zynex website?

https://www.zynex.com

Is Zynex in the S&P 500?

No, Zynex is not included in the S&P 500 index

Is Zynex in the NASDAQ 100?

No, Zynex is not included in the NASDAQ 100 index

Is Zynex in the Dow Jones?

No, Zynex is not included in the Dow Jones index

When does Zynex report earnings?

The next expected earnings date for Zynex is 26 July 2024